Axial Therapeutics
Woburn · Biotechnology, Healthcare, Health Care
Axial Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases. The company is the scientific leader in the biological role of the microbiome gut-brain axis and its influence on the central nervous system. Harnessing its unique expertise in the microbiome, Axial is developing small molecule drugs with defined mechanisms of act
Key facts
- Headquarters
- Woburn
- Employees
- 12
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Private
- Website
- axialtx.com
- Company page
Recent activity at Axial Therapeutics
- : Axial Therapeutics
- : Axial Therapeutics
- : AXIAL THERAPEUTICS, INC.
- : Axial Therapeutics Raises $37.25 Million In Series C Financing To Advance Its Pipeline Of Gut-Targeted Small Molecule Drugs For Neurological Diseases And Disorders
- : AXIAL THERAPEUTICS, INC.
- : AXIAL BIOTHERAPEUTICS, INC.
- : AXIAL BIOTHERAPEUTICS, INC.
- : AXIAL BIOTHERAPEUTICS, INC.
- : AXIAL BIOTHERAPEUTICS, INC.
Axial Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2025 | Venture | $19.4M |
| Oct 2023 | Venture | $27.4M |
| Oct 2021 | Series C | $37.3M |
| May 2021 | Seed | $4.8M |
| May 2020 | Venture | $7.8M |
Leadership
- A. Stewart Campbell, Director
- A. CAMPBELL, Executive Officer, Director
- JAMES BLAIR, Director
- RICHARD ALDRICH, Director
- SARKIS MAZMANIAN, Director
- RONALD JR., Director
- ERIC FORTELLE, Director
- SAKAE ASANUMA, Director
- SCOTT BRUN, Director
- DAVID DONABEDIAN, Executive Officer, Director
Verified email and direct lines for Axial Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Axial Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Axial Therapeutics in the news
- Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism - Yahoo Finance (Sep 26, 2023)
- Nature Medicine publishes full results from axial therapeutics’ phase 1b/2a clinical trial in Autism Spectrum Disorder (ASD) - EurekAlert! (Mar 02, 2022)
- Axial Therapeutics Raises $37.25 Million in Series C Financing to Advance its Pipeline of Gut-Targeted Small Molecule Drugs for Neurological Diseases and Disorders - Business Wire (Oct 13, 2021)
- Axial Therapeutics Receives Second Research Grant Award - GlobeNewswire (Jun 20, 2023)
- Axial Therapeutics’ Scientific Founder Sarkis Mazmanian, Ph.D., to Present Research Highlighting the Gut-Brain Connection in Autism Spectrum Disorder (ASD) at TACA’s Autism Action Conference - Business Wire (Apr 05, 2022)
Companies similar to Axial Therapeutics
- Enveric Biosciences · Biotechnology, Healthcare, Health Care
- Pneuma Respiratory · Biotechnology, Healthcare, Health Care
- Yarrow Bioscience · Biotechnology, Healthcare, Health Care
- Cocrystal Pharma, Inc. · Biotechnology, Healthcare, Health Care
- COSCIENS Biopharma · Biotechnology, Healthcare, Health Care
About Axial Therapeutics: questions and answers
What does Axial Therapeutics do?
Axial Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases. The company is the scientific leader in the biological role of the microbiome gut-brain axis and its influence on the central nervous system. Harnessing its unique expertise in the microbiome, Axial is developing small molecule drugs with defined mechanisms of act
Where is Axial Therapeutics headquartered?
Axial Therapeutics is headquartered in Woburn.
How many employees does Axial Therapeutics have?
Axial Therapeutics has about 12 employees.
Has Axial Therapeutics raised funding?
Yes. Fundz has recorded 5 funding events for Axial Therapeutics. The most recent, $19.4M, was in Feb 2025.
What is the latest news on Axial Therapeutics?
On Feb 11, 2025, Axial Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy